4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Laboratorios Poen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol - Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Completed | Laboratorios Poen | 84 | 2023-03-07 | 2024-11-06 |
| Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment Bepotastine Besilate 1.5% PF, Olopatadine Hydrochloride 0.2% BAK - Allergic Conjunctivitis | Phase 4 | Completed | Laboratorios Poen | 97 | 2021-03-10 | 2022-12-15 |
| Difluprednate vs. a Prednisolone Acetate - Phenylephrine on Post-operative Inflammation Following Cataract Surgery. Difluprednate Ophthalmic Emulsion 0.05%, Prednisolone Acetate 1% Phenylephrine hydrochloride 0,12% ophthalmic solution - Cataract | Phase 4 | Completed | Laboratorios Poen | 255 | 2019-03-24 | 2023-05-12 |
| Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost Latanoprost Ophthalmic Product - Primary Open-angle Glaucoma | Phase 4 | Completed | Laboratorios Poen | 103 | 2017-01-06 | 2017-11-08 |
Glaucoma, Open-Angle (2) · Ocular Hypertension (2) · Cataract (1) · Conjunctivitis, Allergic (1) · Glaucoma (1)
Olopatadine Hydrochloride (1) · OmpF protein (1) · bepotastine besilate (1) · dorzolamide (1) · dorzolamide-timolol combination (1) · prednisolone acetate (1)
Argentina (4)
Alejo Peyret, PhD (1) · Daniel Grigera, PhD (1) · Javier Casiraghi, PhD (1) · Jorge Tosi, M.D. (1)